← Back
Data updated: Mar 10, 2026
IMMUNOCORE LTD
OncologyInfectious Disease
IMMUNOCORE LTD is a biotechnology company focused on Oncology, Infectious Disease.
2022
Since
1
Drugs
-
Trials
1
Approved (2yr)
Key Drugs
No active drugs
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Oncology 96%
1 drugs Phase 3: 2 Phase 2: 2 Phase 1: 7
Infectious Disease 4%
0 drugs Phase 1: 1
Pipeline Strength Pro
Loading...
Active (1)
Discontinued (0)
Company Info
- First Approval
- 2022-01-25
- Latest
- 2024-06-27
- Applications
- 1